LCCC 0417: COX-2 INHIBITORS ON TUMOR ANOREXIA-CACHEXIA SYNDROME - CANCER

LCCC 0417：COX-2 抑制剂对肿瘤厌食-恶病质综合征 - 癌症的影响

• 批准号: 7377542
• 负责人: MARION E COUCH
• 金额: $ 0.67万
• 依托单位: UNIV OF NORTH CAROLINA CHAPEL HILL
• 依托单位国家: 美国
• 财政年份: 2005
• 资助国家: 美国
• 起止时间: 2005-12-01 至 2006-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7377542
• 关键词: LCCC; 0417; COX; INHIBITORS; TUMOR

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The purpose of this study is to see if Celebrex can improve cachexia in people with head, neck, or gastrointestinal tract cancer.

该子项目是利用 NIH/NCRR 资助的中心拨款提供的资源的众多研究子项目之一。子项目和研究者 (PI) 可能已从另一个 NIH 来源获得主要资金，因此可以在其他 CRISP 条目中得到体现。列出的机构是中心的机构，不一定是研究者的机构。本研究的目的是了解西乐葆是否可以改善头颈癌或胃肠道癌症患者的恶病质。